These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9121269)

  • 41. A Molecular Modeling Study of the Hydroxyflutamide Resistance Mechanism Induced by Androgen Receptor Mutations.
    Liu HL; Zhong HY; Song TQ; Li JZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Androgens and androgen receptor in prostate cancer].
    Miyoshi Y; Kubota Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():489-93. PubMed ID: 16689355
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer.
    Pitts WR
    BJU Int; 2004 May; 93(7):1119-20. PubMed ID: 15142186
    [No Abstract]   [Full Text] [Related]  

  • 44. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.
    Ye D; Mendelsohn J; Fan Z
    Clin Cancer Res; 1999 Aug; 5(8):2171-7. PubMed ID: 10473102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antiandrogen withdrawal syndrome].
    Akimoto S
    Nihon Rinsho; 1998 Aug; 56(8):2135-9. PubMed ID: 9750522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
    Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
    Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Alternative antiandrogen therapy with flutamide in patients with castration-resistant prostate cancer : a single center experience].
    Takada T; Ishizuya Y; Okada T; Ueda T; Inoue H; Hara T
    Hinyokika Kiyo; 2011 Jun; 57(6):291-5. PubMed ID: 21795830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salutary clinical response of prostate cancer to antiandrogen withdrawal: assessment of flutamide in an in vitro paradigm predictive of tumor growth enhancement.
    Brandes LJ; Queen GM; LaBella FS
    Clin Cancer Res; 1997 Aug; 3(8):1357-61. PubMed ID: 9815819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon.
    Sica G; Dell'Acqua G; Iacopino F; Fattorossi A; Marchetti P; van der Kwast TH; Pavone-Macaluso M
    Urol Res; 1994; 22(1):33-8. PubMed ID: 8073539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen and estrogen receptors in splenic T lymphocytes: effects of flutamide and trauma-hemorrhage.
    Samy TS; Schwacha MG; Cioffi WG; Bland KI; Chaudry IH
    Shock; 2000 Oct; 14(4):465-70. PubMed ID: 11049111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y
    Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgen receptor blockade in the MPOA or VMN: effects on male sociosexual behaviors.
    Harding SM; McGinnis MY
    Physiol Behav; 2004 Jun; 81(4):671-80. PubMed ID: 15178162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of the antiandrogen 2-hydroxyflutamide on the androgen receptor expression in the porcine ovarian follicles - an in vitro study.
    Duda M; Wolna A; Knapczyk-Stwora K; Durlej-Grzesiak M; Knet M; Tabarowski Z; Slomczynska M
    Reprod Domest Anim; 2013 Jun; 48(3):454-62. PubMed ID: 23113830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
    Grant ES; Batchelor KW; Habib FK
    Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.
    Tammela TL; Häggman M; Ladjevardi S; Taari K; Isotalo T; Lennernäs H; Weis J; von Below C; Wassberg C; Lennernäs B; Tolf A; Axén N; Gölander CG; Ahlström H
    J Urol; 2017 Dec; 198(6):1333-1339. PubMed ID: 28736321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgen Receptor Antagonists Suppress Immunotherapy in Prostate Cancer.
    Cancer Discov; 2016 Jun; 6(6):569. PubMed ID: 27102077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of antiandrogens and their mechanisms of action: a case study (anandron).
    Raynaud JP; Fiet J; Le Goff JM; Martin PM; Moguilewsky M; Ojasoo T
    Horm Res; 1987; 28(2-4):230-41. PubMed ID: 3331376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behavioral effects of an antiandrogen in adult male rhesus macaques (Macaca mulatta).
    Deputte BL; Johnson J; Hempel M; Scheffler G
    Horm Behav; 1994 Jun; 28(2):155-64. PubMed ID: 7927282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of the anti-androgen hydroxyflutamide on in vitro development of mouse embryos.
    Yallampalli C; Osuamkpe C; Nagamani M
    J Reprod Fertil; 1993 Nov; 99(2):467-70. PubMed ID: 8107028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.